Strategy (MSTR) has tapped equity markets again, raising $216 million in a new stock sale earmarked for bitcoin accumulation — the company's signature capital allocation strategy under Michael Saylor. Bitcoin itself retreated below $62,000 following the announcement, giving back the weekend's gains and removing the near-term price catalyst that typically supports MSTR's premium valuation.
The move matters because MSTR trades as a leveraged BTC proxy, commanding a premium over its net asset value that only holds if markets expect continued bitcoin appreciation. The enrichment data paints a stark picture: revenues of $477M are growing at just 3% YoY, gross margins are healthy at 68.7%, but net margins are a staggering -806% — almost entirely a function of BTC-related accounting losses and debt service costs. Diluted EPS sits at -$15.23.
The bull case rests entirely on BTC appreciation outpacing the dilution from serial equity raises. If bitcoin re-accelerates toward prior highs, MSTR's BTC-per-share metric can still improve and the premium to NAV is defensible. But each equity raise is dilutive and the structural losses are deepening — if BTC stagnates or falls, the equity is arguably worth far less than current prices imply.
What to watch: the pace of BTC recovery relative to MSTR's rate of dilution, and whether the mNAV premium compresses further as the raise-and-buy cycle attracts more scrutiny from institutional holders. The $62K BTC level is a near-term technical pivot.